KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
81 hedge funds and large institutions have $28.8M invested in Kalaris Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 35 closing their positions.
Holders
81
Holders Change
-9
Holders Change %
-10%
% of All Funds
1.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
22
Reduced
20
Closed
35
Calls
$284K
Puts
$5K
Net Calls
+$279K
Net Calls Change
+$322K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$2.65M |
| 2 |
2
Morgan Stanley
New York
|
$697K |
| 3 |
WP
3
Woodline Partners
San Francisco,
California
|
$1.71M |
| 4 |
4
Renaissance Technologies
New York
|
$518K |
| 5 |
5
D.E. Shaw & Co
New York
|
$172K |
